ProPhase Labs Inc (PRPH)
2.19
+0.05
(+2.34%)
USD |
NASDAQ |
Nov 04, 16:00
2.19
0.00 (0.00%)
After-Hours: 20:00
ProPhase Labs Total Assets (Quarterly): 93.68M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 93.68M |
| March 31, 2024 | 90.03M |
| December 31, 2023 | 91.93M |
| September 30, 2023 | 91.71M |
| June 30, 2023 | 91.06M |
| March 31, 2023 | 95.37M |
| December 31, 2022 | 87.65M |
| September 30, 2022 | 97.88M |
| June 30, 2022 | 97.95M |
| March 31, 2022 | 99.66M |
| December 31, 2021 | 89.30M |
| September 30, 2021 | 72.63M |
| June 30, 2021 | 76.32M |
| March 31, 2021 | 85.44M |
| December 31, 2020 | 31.40M |
| September 30, 2020 | 23.03M |
| June 30, 2020 | 12.38M |
| March 31, 2020 | 11.87M |
| December 31, 2019 | 12.27M |
| September 30, 2019 | 15.60M |
| June 30, 2019 | 15.80M |
| March 31, 2019 | 16.57M |
| December 31, 2018 | 20.74M |
| September 30, 2018 | 20.58M |
| June 30, 2018 | 22.12M |
| Date | Value |
|---|---|
| March 31, 2018 | 34.22M |
| December 31, 2017 | 33.66M |
| September 30, 2017 | 39.08M |
| June 30, 2017 | 50.10M |
| March 31, 2017 | 57.54M |
| December 31, 2016 | 12.80M |
| September 30, 2016 | 12.79M |
| June 30, 2016 | 11.54M |
| March 31, 2016 | 13.32M |
| December 31, 2015 | 14.83M |
| September 30, 2015 | 13.85M |
| June 30, 2015 | 12.04M |
| March 31, 2015 | 14.99M |
| December 31, 2014 | 16.06M |
| September 30, 2014 | 17.92M |
| June 30, 2014 | 19.76M |
| March 31, 2014 | 17.27M |
| December 31, 2013 | 17.42M |
| September 30, 2013 | 16.67M |
| June 30, 2013 | 15.07M |
| March 31, 2013 | 16.14M |
| December 31, 2012 | 16.66M |
| September 30, 2012 | 16.53M |
| June 30, 2012 | 15.18M |
| March 31, 2012 | 17.92M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
11.87M
Minimum
Mar 2020
99.66M
Maximum
Mar 2022
71.13M
Average
89.30M
Median
Dec 2021
Total Assets (Quarterly) Benchmarks
| Fonar Corp | 214.25M |
| XWELL Inc | 36.29M |
| Applied DNA Sciences Inc | 16.69M |
| Veracyte Inc | 1.234B |
| OncoCyte Corp | 74.72M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 49.60M |
| Shareholders Equity (Quarterly) | 44.08M |
| Debt to Equity Ratio | 0.3083 |
| Current Ratio | 1.576 |
| Net Debt Paydown Yield | -0.99% |